Dysport is not inherently bad for you. It has been FDA-approved since 2009 and is used by millions of people for both cosmetic and medical purposes. Like all botulinum toxin products, it carries real risks, but most people tolerate it well when it’s administered correctly. The key is understanding what those risks actually look like and who faces a higher chance of problems.
What Dysport Does to Your Body
Dysport is a form of botulinum toxin type A. It works by temporarily blocking the nerve signals that tell muscles to contract. For cosmetic use, that means smoother skin where frown lines form. For medical use, it helps people with conditions like cervical dystonia (involuntary neck muscle contractions) or spasticity from stroke or cerebral palsy.
The effects are localized and temporary, typically lasting three to four months before the nerve signals recover and muscles start contracting normally again. Your body doesn’t build up a toxic load from repeated treatments. Each session works independently.
Common Side Effects
Most side effects are mild and short-lived. What you experience depends on where the injection goes.
For cosmetic injections (frown lines between the eyebrows), clinical trials found the most common reactions at 2% or higher were nasal congestion, headache, pain at the injection site, minor swelling or drooping of the eyelid, sinus irritation, and nausea. Eyelid drooping is the one that worries people most, but it’s temporary and resolves as the toxin wears off.
For medical uses involving larger doses, side effects tend to be more noticeable. In cervical dystonia patients receiving 500 units, more than 5% experienced muscle weakness, difficulty swallowing, dry mouth, fatigue, headache, and voice changes. In adults treated for leg spasticity, falls, muscle weakness, and limb pain were the most frequent complaints. These higher rates reflect the larger doses and deeper muscle targets involved in medical treatment compared to cosmetic procedures.
The Serious Risk: Toxin Spread
Dysport carries an FDA black box warning, the most serious type of safety alert. The concern is that the toxin can sometimes migrate away from the injection site and affect muscles elsewhere in the body. This can cause generalized muscle weakness, double or blurred vision, drooping eyelids, difficulty swallowing, voice changes, loss of bladder control, and breathing problems.
These symptoms have been reported anywhere from hours to weeks after injection. Difficulty swallowing and breathing can be life-threatening, and deaths have been reported. This warning applies to all botulinum toxin products, not just Dysport.
The risk is highest in children being treated for spasticity and in adults who already have underlying conditions affecting their muscles or nerves. For healthy adults getting cosmetic doses, this kind of spread is rare. But it’s the reason Dysport should only be administered by a trained, qualified provider who understands proper dosing and injection placement.
Who Should Not Get Dysport
Certain people face significantly higher risks. If you have a neuromuscular disorder such as myasthenia gravis, Lou Gehrig’s disease (ALS), or Lambert-Eaton syndrome, even standard doses of Dysport can cause severe difficulty swallowing or dangerous breathing problems. These conditions already compromise the connection between nerves and muscles, so adding a toxin that blocks those signals can tip the balance in a serious way.
There’s also a less obvious contraindication: cow’s milk protein allergy. Dysport contains lactose as an inactive ingredient and may contain trace amounts of cow’s milk protein. If you have a confirmed milk protein allergy (not just lactose intolerance), Dysport is not considered safe for you.
Dysport During Pregnancy and Breastfeeding
The FDA advises against using Dysport (or any botulinum toxin) during pregnancy and breastfeeding. There simply isn’t enough human safety data to confirm it’s harmless to a developing baby.
For breastfeeding specifically, early research is somewhat reassuring. A study published in Frontiers in Drug Safety and Regulation measured botulinum toxin levels in breast milk after facial injections and found only trace amounts, peaking around 167 picograms per milliliter at about four days post-injection. The researchers concluded these quantities were likely too small to pose a risk to an infant and that facial injections probably don’t require stopping breastfeeding. Still, this is preliminary data from a small study, so the official guidance remains cautious.
Cosmetic vs. Medical Doses
Context matters when evaluating risk. A cosmetic treatment for frown lines uses a relatively small amount of Dysport injected into superficial facial muscles. A medical treatment for cervical dystonia or limb spasticity can involve several times that dose injected into larger, deeper muscles. The side effect profiles reflect this difference. Cosmetic patients generally experience mild, localized reactions. Medical patients are more likely to report muscle weakness, swallowing difficulty, and fatigue.
If you’re considering Dysport purely for cosmetic reasons, your risk profile is on the lower end of the spectrum. That doesn’t mean zero risk, but the overwhelming majority of cosmetic patients complete treatment without any significant problems.
What Actually Makes Dysport Dangerous
The toxin itself is predictable. What makes it dangerous in practice is improper use: wrong dose, wrong injection site, wrong patient. Getting Dysport at a med spa with an inexperienced injector, using doses that haven’t been calibrated to your anatomy, or failing to disclose a relevant medical condition are the scenarios where things go wrong. The product’s safety record in clinical trials reflects careful, controlled administration by trained professionals. Your outcome depends heavily on who is holding the needle.